EMJ Neurology 8 [Supplement 2] . 2020

In this issue

In this supplement to EMJ Neurology, two leading experts in multiple sclerosis (MS), Prof Tjalf Ziemssen and Prof Diego Centonze, explored the sphingosine 1-phosphate (S1P) receptor modulators drug class and how they can be utilised in the management of patients with MS.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given